FP06 Optimized engineered prime editing guide RNAs unlock efficient prime editing for recessive dystrophic epidermolysis bullosa gene correction

Clicks: 2
ID: 318443
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #128 of 302 articles by views in the british journal of dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 302 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction and aims Recessive dystrophic epidermolysis bullosa (RDEB) is caused by pathogenic variants in COL7A1, resulting in severe skin fragility and remains without a curative treatment. Prime editing (PE), a versatile CRISPR-derived gene editing tool, capable of inducing insertions/deletions (indels) and all types of substitutions holds a great potential to provide a cure for RDEB. In this study, we hypothesized that installation of silent modifications integrated in the engineered PE guide RNA (epegRNA) could make on-target corrections evade DNA mismatch repair process, thereby increasing PE editing efficacy. Methods We first used PE5bmax with rationally designed epegRNAs to correct two pathogenic variants from patients with RDEB harbouring heterozygous COL7A1 c.5047C>T and c.1732C>T. Based on mechanistic insights from these experiments, an additional pathogenic variant, heterozygous c.7786delG leading to null collagen VII (C7), was targeted using PE6c. Following electroporation of PE mRNA into primary patient fibroblasts and a 7-day incubation, editing was validated by Sanger and Nanopore sequencing. Translation of gene correction into C7 restoration was assessed by Western blot analysis. Results On-target correction efficiencies of 32% for c.5047C>T and 16% for c.1732C>T were achieved across three technical replicates. In both cases, editing efficiency was strongly influenced by the number of silent modifications incorporated into the epegRNA. Using a similar approach, PE-mediated correction of the c.7786delG variant reached 65% across three independent experiments, representing the highest efficiency reported to date for COL7A1-targeting PE. Western blot analysis demonstrated 50% restoration of C7 in cell lysates and 20% in the supernatant. Conclusions This study demonstrates that rational epegRNA design incorporating silent modifications significantly enhances PE efficiency for COL7A1 correction in fibroblasts of patients with RDEB. High and reproducible editing efficiencies were achieved across multiple pathogenic variants, accompanied by substantial restoration of collagen VII protein. Building on these results, functional assessment in three-dimensional human skin constructs will be performed to evaluate phenotypic rescue.
Reference Key
openalex_W7165618866 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Aidin Kazemizadeh, Prashant Kumar, Lukasz Laczmanski, John McGrath, Joanna Jackow-Malinowska
Journal the british journal of dermatology
Year 2026
DOI
10.1093/bjd/ljag151.029
URL
https://doi.org/10.1093/bjd/ljag151.029
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.